Acutis Diagnostics Leverages SOPHiA GENETICS Technology to C

The New Assay Will Screen Patients for Clinical Trials and Help Increase Data Analysis for Clinical Researchers SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space

Related Keywords

Al Harthi , Abdel Halim , Ken Freedman , Nasdaq , Instagram , Facebook , Linkedin , Exchange Commission , Research Use , Twitter , New Assay Will Screen Patients , Clinical Trials , Help Increase Data Analysis , Acutis Diagnostics , Acutis Diagnostic , Hereditary Cancers Solution , Chief Scientific Officer , Executive Vice President , Chief Revenue Officer , Research Use Only , Looking Statements , Genomic Medicine , Acutis , Iagnostics , Beverages , Sophia , Enetics , Technology , Create , Text , Generation , Sequencing , Pest ,